The aims of this study were to measure the amount of starch from partially resistant starches (retrograded and complexed high-amylose cornstarches) escaping smallintestinal digestion in healthy humans by use of an intubation method and to compare these data with data obtained by indirect in vitro methods. Experiments were carried out in vivo in 6 healthy humans by using ileal intubation and stool analysis and in vitro by using 3 different methods for analyzing resistant starch. In intubated subjects, 51 ± 2% of the retrograded and 21 ± 2% of the complexed starch was delivered to the ileum and was fermented almost completely in the colon. In vitro estimates of the absorption of resistant starch were much lower. We conclude that technologically modified starches may substantially increase the amount of carbohydrate available for colonic fermentation in humans, but that in vitro measurements of resistant starch are inaccurate for predicting malabsorption in healthy humans.
INTRODUCTION
Resistant starch (RS) is the sum of starch and products of starch degradation not absorbed in the small intestine of healthy humans (1) . If RS is, as proposed by several authors, a new category of dietary fiber able to prevent or possibly treat some metabolic and gastrointestinal diseases, new technological treatments or new foods should be promoted (2) . One kind of RS results from hydrothermic treatment and storage conditions. Retrogradation of starch occurs after thermal treatment, when disorganized starch macromolecules are kept at room or low temperature (4 ЊC for instance) without prior dehydration. This evolution of starch is characterized by recrystallization of amylose and amylopectin in forms highly resistant to amylases and is more extensive when the ratio of amylose to amylopectin is high (3) . Some lipids can also become complexed with amylose during hydrothermic treatment. For example, fatty acids and monoacylglycerols naturally present in cereals or added to flours before treatment can be entrapped by amylose. This makes starch less available to enzymatic digestion because amylose-lipid complexes are hydrolyzed more slowly than is free amylose (4) . However, these results are from a study performed in rats and no similar data for humans are available.
According to the physiologic definition of RS, its content in foods should be determined either by techniques measuring the amount of starch delivered to the human colon or by chemical assays able to accurately predict RS content. The aims of this study were 1) to assess with a direct in vivo method (an intubation technique) the small-intestinal and colonic digestion of high-amylose starches thermally treated in the absence or presence of lipids, and 2) to compare these results with those obtained by indirect methods (in vitro analysis of RS).
SUBJECTS AND METHODS

Subjects
Six healthy volunteers (5 women, 1 man) with no history of gastrointestinal disease, recent treatment with antibiotics, or use of laxatives were studied. The subjects ranged in age from 23 to 27 y and all gave their written, informed consent to participated in the protocol, which was approved by the Saint-Lazare Ethics Committee and was in accord with the ethical standards of the French legislation for human experimentation. cooking: 10.5 kg dry starch (97.98% dry matter) was added to the extruder per hour in 13.5 L water at 170 ЊC; the rotation speed of the extruder's screws was 250 rpm. After 72 h at 4 ЊC, the product was manually broken into small pellets (< 1 cm in diameter) and then dried at 60 ЊC in an air drier for 2 h.
Complexed high-amylose starch (CAS) was produced as follows: 10 kg (dry matter basis) native high-amylose cornstarch was mixed with 1.1 kg (dry matter basis) monoacylglycerols (Dimodan; Grindsted, Trappes, France) and 30 L water in a Lödige reactor (Lödige, Paderborn, Germany), in which the temperature was rapidly increased to 110 ЊC. This temperature was maintained for 90 min and then slowly decreased (over 30 min) to 80 ЊC. After 72 h at room temperature, the product was dried by following the same procedure as for RAS.
The physical characteristics of both starches were described previously (5) . CAS has a V-type X-ray diffraction pattern, whereas RAS is a B-type starch. RAS has been selected as a ref- 
In vitro measurement of total starch and RS contents of the experimental starches
Total starch was analyzed according to Karkalas (6) . Starch was initially treated with 1 mol NaOH/L for 30 min and then hydrolyzed successively with thermostable bacterial ␣-amylase and fungal glucan 1,4-␣-glucosidase (amyloglucosidase). The glucose obtained was analyzed by the hexokinase-glucose-6-phosphate 1-dehydrogenase method (Boehringer Mannheim, Mannheim, Germany).
The RS content of the experimental starches was determined in vitro according to Champ (7), Englyst et al (8) , and Siljeström and Asp (9) . RS was measured as the residual starch after ␣-amylolysis under conditions that depended on the analytic method used. According to Champ (7), a starch sample was first hydrolyzed with pancreatic ␣-amylase. The hydrolysis products were then extracted in 80% ethanol and the residue was solubilized with 2 mol KOH/L and hydrolyzed with amyloglucosidase. Finally, glucose was analyzed as described for the analysis of total starch. The method of Englyst et al (8) included a pepsin incubation before the enzymatic hydrolysis of starch, which was performed with pancreatin, amyloglucosidase, and ␤-fructofuranosidase (invertase). A sample collected after 2 h of hydrolysis and analyzed for glucose (GOD-PAP test combination; Boehringer Mannheim) allowed the measurement of digestible starch. The remaining fraction was treated at 100 ЊC and then solubilized in a solution of potassium hydroxide before being hydrolyzed with amyloglucosidase and analyzed as glucose. The RS value was calculated as the difference between the total starch and the digestible starch contents. In the method of Siljeström and Asp (9) , RS was calculated as the starch remaining in the fiber residue obtained by using the method of Asp et al (10) ; this starch is available for amyloglucosidase digestion only after solubilization with 2 mol KOH/L.
In vivo starch recovery from the distal ileum and stools
The in vivo study was divided into two 9-d periods that were separated by ≥ 15 d. All subjects were given in random order a basal diet to which 97.5 g starch from RAS or CAS (ie, 100 g RAS or 110 g CAS) was added in 3 equal doses. We used the same basal diet as in a previous study (11) , which provided 9.8 MJ/d, with 50% of energy as available carbohydrate (85% from starch and 15% from simple sugars), 18% of energy as protein, and 32% of energy as fat ( Table 1 ). The 3 meals had similar energy contents and proportions of proteins, lipids, and carbohydrates.
The first 4 d of each period were recorded as an equilibration period. On days 5 and 6, stools were collected from each subject, weighed individually, and stored at Ϫ20 ЊC. On day 8, subjects were intubated with a triple-lumen polyvinyl tube; the transit of the tube down the gut was aided by a terminal-inflatable bag containing mercury (one lumen was used to inflate this bag). When the bag had reached the cecum, which was confirmed fluoroscopically, it was deflated and the subjects had to remain in a semirecumbent position. One lumen was used to sample ileal content 5 cm above the ileocecal junction and the other lumen, 25 cm proximal to the aspiration port, was used for perfusion. The perfusate contained 154 mmol NaCl/L and 10 g polyethylene glycol (PEG) 4000/L as a recovery marker to estimate water flow through the distal ileum. The solution was kept at 37 ЊC and stirred until the end of perfusion. On day 9 of each period, ileal perfusion was started at 0700 at a rate of 2 mL/min. After 1 h of equilibration, subjects were given a breakfast similar to that provided during the previous days and containing 100 g white bread and 33 or 37 g RAS or CAS, respectively (to provide the same amount of starch: 32.5 g) ( Table 1) . White bread was used in the meals because its RS content is low, as determined earlier both in vitro [0.54% RS (8)] and in ileostomates [0.99% RS (12)], and thus was considered to be only a minor interference with the RS coming from the experimental meals. Similarly, during the short adaptation period (days 1-7), the starchy foods were chosen to contain highly digestible starch with low RS contents and no unfermentable starch ( Table 1) . Intestinal contents were aspirated for 14 h, during which time subjects did not eat or drink. Intestinal contents were collected continuously on ice by manual aspiration to aspirate as much fluid as possible. Samples were divided into 30-min aliquots and the pH of the ileal fluid was measured immediately. pH was always in the alkaline range (7.5-8.5).
Five milliliters of each sample was then frozen at Ϫ20 ЊC for measuring amylase activity and PEG 4000 concentration. The remaining portion of each sample was frozen in liquid nitrogen and then freeze-dried. This treatment was used to prevent bacterial degradation of carbohydrates and to limit physical and chemical changes of residual starch during freezing and storage. Maintenance of the tube position was confirmed fluoroscopically at the end of all experiments. Total starch in the diets and in ileal and fecal samples was analyzed according to Karkalas (6) . A portion of each ileal sample was centrifuged at 1000 ϫ g for 15 min at 4 ЊC. ␣-Amylase activity was measured in the supernate by a quantitative assay with a water-insoluble, cross-linked starch polymer as a substrate (Phadebas amylase test; Pharmacia Diagnostics AB, Uppsala, Sweden). One unit of amylase activity was defined as the amount of enzyme catalyzing the hydrolysis of 1 mol glucosidic linkage per minute at 37 ЊC. The PEG concentration of the ileal samples was measured by the turbidimetric method (13) .
The volume flowing through the terminal ileum for each 30-min period of sampling was calculated by cold PEG dilution without subtraction of the perfused volume (14) . The amounts of total starch and amylase in each ileal sample were determined from the calculated ileal volume and from the corresponding concentrations of starch and amylase. Fourteen-hour total ileal contents were calculated by summing the results for individual periods.
The weight of stools expelled by the subjects during each period was expressed as mean 24-h output. From recovery of starch in stools, fecal digestibility was calculated as follows: (amount of experimental starch ingested Ϫ amount of starch in feces) ϫ 100/amount of experimental starch ingested. The starches from starchy foods, including bread, were considered to be totally digestible and were not taken into account in the calculation.
Statistical analysis
Data are expressed as means ± SEM. Means of ileal outputs of water, ␣-amylase, and starch for the 2 experimental periods were compared by Wilcoxon's signed-rank test. The same statistical test was applied to compare the means of starch recovery from the stools. Data were analyzed with STATVIEW (F.4.11; Abacus Concepts Inc, Berkeley, CA).
RESULTS
Total starch and RS contents of the experimental starches as analyzed in vitro
Because of the presence of monoacylglycerol, the starch content of CAS was Ϸ10% lower than that of RAS. The ratio of RS to total starch was dependent on the analytic method used ( Table  2 ). The analytic procedure described by Siljeström and Asp (9) resulted in the lowest values, about half of those obtained with the methods of Champ (7) and Englyst et al (8) for RAS.
Volume flow in the distal ileum and recovery of amylase during intestinal intubation
The mean water flow through the distal ileum during the 14-h collection period was 2245 ± 211 and 2039 ± 294 mL for the RAS and CAS periods, respectively (P = 0.21). The mean amounts of ␣-amylase recovered over 14 h were also not significantly different for the RAS and CAS periods (195 ± 37 compared with 340 ± 128 kIU, P = 0.26).
Starch recovery from the distal ileum as measured by intestinal intubation
The mean amount of starch not absorbed in the small intestine during the 14-h aspiration period was significantly higher (P < 0.01) after the ingestion of the meal containing RAS (16.5 ± 0.7 g; range: 13.6-19.0 g) than after the meal containing CAS (6.9 ± 0.5 g; range: 5.2-8.0 g) (Figure 1) . When expressed in relation to the amounts of starch ingested from experimental starches, the mean percentages of unabsorbed starch were 51 ± 2% (range: 42-59%) and 21 ± 2% (range: 16-25%) for the 1 RAS, retrograded high-amylose cornstarch; CAS, complexed highamylose cornstarch.
2 Starch and products of starch digestion recovered at the end of the ileum by the intubation technique.
3 x -± SEM; range in parentheses.
RAS and CAS meals, respectively (P < 0.01). The time to recover half of the unabsorbed starch was similar in both periods: 5.5 h (range: 3-8 h) and 5 h (range: 3.5-6.5 h) for the RAS and CAS meals, respectively (Figure 1) . However, the time required to recover all of the unabsorbed starch was dependent on the starch; it was 14 and 12.5 h for the RAS and CAS meals, respectively (P < 0.05).
Starch recovery from stools
Mean 24-h fecal weights during the 2 periods were not significantly modified by the nature of the starch ingested (140 ± 28 and 115 ± 23 g for the RAS and CAS periods, respectively). The amounts of starch recovered in the feces were low in 5 of the 6 subjects. Mean total digestibilities of RAS and CAS were 100% in these 5 subjects, whereas for the sixth subject the digestibilities were 84% and 97%, respectively.
DISCUSSION
High-amylose starch is particularly susceptible to retrogradation (2) . To promote extensive retrogradation, high-amylose starch was extruded under optimal conditions (high incorporation of water and low temperature) to completely destroy the initial crystalline structure of the starch, but also to obtain a wet product that could develop a new crystalline structure during storage at 4 ЊC. This evolution from the raw amylomaize starch to the final product has been confirmed by chemical and physical characterizations (5). Complexation of high-amylose starch with linear molecules of lipids can also result in slowly digestible starch (2, 4) .
RS analysis confirmed the huge variability in RS measurement depending on the method used (7). The method described by Siljeström and Asp (9) derived from the Association of Official Analytical Chemists' procedure for fiber analysis resulted in the lowest values, whereas those described by Champ (7) and Englyst et al (8) gave similar RS contents. However, whatever the method, the RS content of RAS was much higher than that of CAS. This result agrees with the fact that complexation prevents part of the amylose from being incorporated into crystallites and probably makes it more accessible to hydrolysis than does retrogradation (15) .
Various techniques are available to determine the amount of carbohydrate that reaches the cecum in humans. Much interest has been paid to the measurement of breath hydrogen as a noninvasive, diagnostic test for carbohydrate malabsorption. When breath-hydrogen production is used to make quantitative estimates of the amount of carbohydrate fermented, each subject must be given a standard dose of unabsorbable lactulose as a calibration step; it is assumed that the volume of hydrogen produced per gram of any carbohydrate fermented is the same as that produced from lactulose. However, Levitt et al (16) and Christl et al (17) showed that this is not always true in vitro and in vivo. Cummings and Englyst (18) compared the measurement of starch digestibility in the small intestine by the ileostomy method and breath-hydrogen test. The breath-hydrogen test with lactulose as a standard underestimated starch malabsorption from potato and banana. Using a whole-body calorimeter, Christl et al (17) also showed that banana starch yielded 39% of the volume of hydrogen excreted from an equivalent dose of lactulose. These discrepancies may be explained by a reduced rate of hydrogen production from RS compared with lactulose or by the utilization of hydrogen produced from RS in other reactions (mainly sulfate reduction and to a lesser extent acetogenesis in non-methane-producing subjects) (17, 19) .
Persons with ileostomies do not have normal guts and may be at risk for physiologic adaptation leading to modified digestion. Major differences between the normal ileum and the ileostomy are the water flow rate and electrolyte absorption (20) . Moreover, it is possible that the flora that inhabits the terminal ileum (21) may break down carbohydrates by fermentation, thus invalidating ileostomy observations. Last, there are few persons with ileostomies today because the conventional ileostomy operation is being replaced more and more by ileoanal anastomosis (21) .
The only means of directly quantifying the ability of the small intestine to digest and absorb ingested carbohydrates is by intubation of the terminal ileum. This method allows the concomitant study of colonic digestion through the collection of stools from the same subjects. However, intubation may influence gastrointestinal function (22) , slowing gastric emptying but shortening small-intestinal transit time. There is currently no evidence that the slight reduction in intestinal residence time impairs the intestinal absorption of carbohydrates. As done previously (23) , in this study we used a modified method that took into account theoretical considerations stressed by Davis et al (24) and Levitt and Bond (25) . There is currently no marker for measuring the ileal flow of a solid meal. However, if recovery of the solid phase was lower than recovery of fluid, this would have led to an underestimation of starch flowing through the distal ileum. Thus, our figures of starch delivery to the colon should be considered minimal values.
Percentages of RS (on a total starch basis) from RAS and CAS, determined by the intubation technique, were 51% and 21%, respectively. Comparison of these results with theoretical intakes of RS determined by in vitro assays showed that none of the 3 in vitro methods used in this study (7) (8) (9) gave accurate estimates of the total in vivo RS. In our study, we assumed that starch from bread was 100% digestible in the small intestine. However, Ϸ2.4% of bread starch could be malabsorbed (12) . Taking into account the correction due to the bread, the percentage of RS in RAS and CAS would become only slightly lower (48% and 18%, respectively). Most of the difference between the in vitro and in vivo measurements can be therefore attributed to the fraction of starch theoretically digestible but in fact truly recovered at the end of the ileum. This fraction is not taken into account in any of the in vitro methods (26) . In 2 of the 6 subjects studied, we analyzed the composition of total unabsorbed starch (26) . In addition to the resistant crystalline fraction, we found glucose, maltose, maltotriose, maltotetraose, and semicrystalline ␣-glucans. These findings agree with those of previous studies in which potentially digestible starch and starch metabolites (including glucose) were found at the end of the human small intestine in healthy subjects (23, 27) . If potentially digestible starch found in the ileal contents was deducted from the total starch recovered, RS from RAS and CAS would be Ϸ40% and 16% of the experimental starches ingested, respectively. The figures would thus become much closer to the values obtained in vitro. In other respects, Englyst et al (8) found good agreement between data obtained in vitro and in vivo in patients with ileostomies. However, in the in vitro system set up by these authors, the hydrolysis conditions were adapted to fit with quantitative values obtained in patients with ileostomies. As in the present study, effluents from patients with ileostomies were shown to contain potentially digestible starch and dextrins (5), which are considered by none of the in vitro analytic methods (26) . Therefore, RS measured in vivo and in vitro by Englyst et al (8) is not, qualitatively, the same starch.
The measurement of total digestibility indicated that most of the ingested starch disappeared in the gastrointestinal tract. Moreover, comparison of the amounts of starch recovered from the terminal ileum after one meal and multiplied by 3 with the amounts measured in the stools showed that 50 ± 3% and 21 ± 2% of RAS and CAS, respectively, was metabolized in the colon.
In conclusion, the ileal digestibility of starches depends strongly on technological treatments that can be applied during the processing of the food (including grinding, cooking, cooling, and storage). Inducing retrogradation of starch during food processing might be a valuable way of increasing the amount of carbohydrate available for colonic fermentation. RS is claimed to be a good substrate for fermentation because of its high rate of production of butyrate and its positive effect on the excretion of secondary bile acids (28) . These data suggest that RS has potentially important effects on bacterial metabolism in the human colon that may be relevant for cancer prevention. Palatable foods with high concentrations of RS can be developed; in contrast, most dietary fiber sources, such as wheat bran, have deleterious effects on the organoleptic properties of foods (29) . At this stage of our understanding of starch digestion in the human small intestine, it is difficult to predict the RS content of foods through in vitro measurements.
